(Q45876830)

17 December 2017

title

Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease (English)

1 reference

17 December 2017

inflammatory bowel diseases

1 reference

1 reference

M D Bhavsar

1

1 reference

17 December 2017

M M Amiji

series ordinal

2

1 reference

17 December 2017

publication date

17 April 2008

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

17

1 reference

17 December 2017

page(s)

1200-1209

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2008.67

exact match

0 references

cites work

Animal models of mucosal inflammation and their relation to human inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Prospects for research in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

State of the art: IBD therapy and clinical trials in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Evolving knowledge and therapy of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

IL-10 and its related cytokines for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

IL-10 deficiency leads to somatic mutations in a model of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

IL-10 gene therapy prevents TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

IL-10 therapy in Crohn's disease: at the crossroads. Treatment of Crohn's disease with the anti-inflammatory cytokine interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Interleukin 10 gene transfer prevents experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Natural polymers for gene delivery and tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Preparation of chitosan self-aggregates as a gene delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Synthetic DNA delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Inflammatory bowel disease: new insights into pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

New genes in inflammatory bowel disease: lessons for complex diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

7 January 2021

Gene transfer technology in therapy: current applications and future goals

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

7 January 2021

Delivery systems for gene-based vaccines

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

7 January 2021

Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

7 January 2021

IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

7 January 2021

Galanin in the trinitrobenzene sulfonic acid rat model of experimental colitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.67

7 January 2021

Identifiers

DOI

10.1038/GT.2008.67

1 reference

17 December 2017

Dimensions Publication ID

1011695641

0 references

1 reference

17 December 2017